Skip to main content
Search
Search
Anywhere
Quick Search anywhere
Enter words / phrases / DOI / ISBN / keywords / authors / etc
Search
Advanced Search
Login
Skip main navigation
Open Drawer Menu
Close Drawer Menu
Home
Journal of Comparative Effectiveness Research
Journal of Patient Centricity
The Evidence Base
Skip slideshow
Journal of Comparative Effectiveness Research
ISSN (print): 2042-6305 • ISSN (online): 2042-6313
Impact Factor: 2.8 (2025) • CiteScore: 4.2 (2025) • Open Access
Read more
Journal of Patient Centricity
ISSN (online): 2978-8579
In partnership with the PCSIG • Open Access
Read more
The Evidence Base
Latest news, opinion and insight into hot topics including RWE, HEOR, HTA and market access
Read more
Latest
The impact of sequential analysis on drug decision-making in Canada
Catherine Beauchemin
,
Jean Lachaine
,
Jean-Eric Tarride
,
Ana Rusu
, and
Stephane Barakat
Journal of Comparative Effectiveness Research
27 Oct 2026
Cost-effectiveness analysis of nanosecond pulsed field ablation against hemithyroidectomy and total thyroidectomy for benign thyroid nodules
Melissa Gomez Montero
,
Ralph P. Tufano
,
Victoria Zaitceva
,
Michael Branagan-Harris
,
Mehdi Javanbakht
, and
Amir Ansaripour
Journal of Comparative Effectiveness Research
26 Oct 2026
One year into JCA, what have we learned and what comes next? Sessions on the agenda at ISPOR Europe 2026
The Evidence Base
2 Nov 2026
Editor’s highlights from the
Journal of Comparative Effectiveness Research
– November 2026
The Evidence Base
2 Nov 2026
Journal of Comparative Effectiveness Research
Open access, peer-reviewed journal offering rapid publication for all aspects of HEOR and related areas
Read More
FROM THE EVIDENCE BASE
29 Oct 2026
Understanding the use of AI in the RWE research lifecycle: Why a living scoping review is needed
29 Oct 2026
Nordic VALO project demonstrates cross-border health data analysis
27 Oct 2026
FDA Grand Rounds RWE series: How real-world evidence informs regulatory decisions in digital health
2 Nov 2026
One year into JCA, what have we learned and what comes next? Sessions on the agenda at ISPOR Europe 2026
2 Nov 2026
Editor’s highlights from the
Journal of Comparative Effectiveness Research
– November 2026
26 Oct 2026
From defining value to reshaping evidence: What to expect from the ISPOR Europe 2026 plenary sessions
2 Nov 2026
One year into JCA, what have we learned and what comes next? Sessions on the agenda at ISPOR Europe 2026
2 Nov 2026
Editor’s highlights from the
Journal of Comparative Effectiveness Research
– November 2026
29 Oct 2026
A dual mandate for branded drug prices
The Evidence Base
Online hub providing the latest news, opinion and insights into HEOR, RWE, HTA and more
Read More
FROM THE EVIDENCE BASE
2 Nov 2026
One year into JCA, what have we learned and what comes next? Sessions on the agenda at ISPOR Europe 2026
2 Nov 2026
Editor’s highlights from the
Journal of Comparative Effectiveness Research
– November 2026
29 Oct 2026
A dual mandate for branded drug prices
29 Oct 2026
Understanding the use of AI in the RWE research lifecycle: Why a living scoping review is needed
.png)
.png)
